Improved diversity in clinical trials can be achieved by exploring opportunities for research in developing countries that have not historically participated in large-scale, industry-sponsored clinical trials.
Lena Low; Martin Lim; Terttu Haring; Serena Chan; David Gebbo; Lucia Rizka Andalucia; Roy Himawan; Indri Rooslamiati; Dona Arlinda
Advertisement
Articles by Lena Low; Martin Lim; Terttu Haring; Serena Chan; David Gebbo; Lucia Rizka Andalucia; Roy Himawan; Indri Rooslamiati; Dona Arlinda
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Are Clinical Trial Diversity Initiatives at Risk of Being Dismantled?
2
Answering the Sustainability Call: Digital Health Technologies and eCOA
3
KRI Overload: When More Isn’t Better
4
Applied Clinical Trials' 2025 State of the Industry Survey
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
